Source: http://www.google.com/patents/US20010041821?dq=U.S.+Patent+No.+4,528,643
Timestamp: 2016-04-29 13:12:32
Document Index: 89331585

Matched Legal Cases: ['art 324', 'art 324', 'art 324', 'art 324', 'art 324', 'art 324', 'art 324', 'art 324', 'art 324', 'art 324']

Patent US20010041821 - Intrapericardial assist method - Google PatentsSearch Images Maps Play YouTube News Gmail Drive More »Sign inPatentsA surgical method for assisting cardiac function utilizes a balloon initially in a collapsed configuration. The balloon is inserted into an intrapericardial space about a patient's heart and is disposed about one portion of the patient's heart. The method further includes inflating the balloon in the...http://www.google.com/patents/US20010041821?utm_source=gb-gplus-sharePatent US20010041821 - Intrapericardial assist methodAdvanced Patent SearchPublication numberUS20010041821 A1Publication typeApplicationApplication numberUS 09/900,126Publication dateNov 15, 2001Filing dateJul 6, 2001Priority dateJun 17, 1993Also published asUS6572529Publication number09900126, 900126, US 2001/0041821 A1, US 2001/041821 A1, US 20010041821 A1, US 20010041821A1, US 2001041821 A1, US 2001041821A1, US-A1-20010041821, US-A1-2001041821, US2001/0041821A1, US2001/041821A1, US20010041821 A1, US20010041821A1, US2001041821 A1, US2001041821A1InventorsPeter WilkOriginal AssigneeWilk Peter J.Export CitationBiBTeX, EndNote, RefManReferenced by (93), Classifications (29), Legal Events (10) External Links: USPTO, USPTO Assignment, EspacenetIntrapericardial assist method
DESCRIPTION OF THE PREFERRED EMBODIMENTS [0053] As illustrated in FIG. 1, an intrapericardial assist or resuscitation assembly comprises an alternately inflatable and collapsible balloon 12 in the form of a cuff. Cuff 12 has an elongate tube 14 extending to a valve device 16 which is connected to a suction source or vacuum generator 18 and to a source 20 of pressurized fluid such as water, saline solution or a gas such as air. In response to signals from a control unit 22, valve device 16 periodically connects cuff 12 to pressure source 20 and alternately to suction source 18, whereby cuff 12 is rapidly and forcefully inflated with a predetermined periodicity. [0054] Control unit 22 may be provided with setting knobs (not illustrated) for varying the rate and maximum pressure that is applied to the cuff upon proper disposition thereof in the intrapericardial space about the heart. [0055] As illustrated in FIGS. 1 and 2, cuff 12 has an arcuate, generally C-shaped configuration in its expanded or inflated state. Cuff 12 has a pair of major C-shaped walls 24 and 26 defining a pressurization chamber 28. Embedded in walls 24 and 26 are spring elements or ribs 30 and 32 which can be bent into a curled configuration (see FIG. 3) but which tend to resume their C-shaped expanded configurations when cuff 12 is placed into an intrapericardial space during a cardiopulmonary resuscitation procedure. [0056] As illustrated in FIGS. 3 and 4, prior to a cardiopulmonary resuscitation procedure, cuff 12 is folded and inserted in a collapsed configuration inside a hollow hypodermic type needle 34. Needle 34 is provided at a distal end 36 with an aperture 38 for the ejection of folded and collapsed cuff 12 by a distally directed stroke of a plunger member 40 upon a disposition of distal end 36 into an intrapericardial space during a cardiopulmonary resuscitation procedure. Distal end 36 is also provided with an electrical sensor for detecting the surface of the heart, as is conventional in known intrapericardial sampling needles. [0057] Distal end 36 of intrapericardial needle 34 is inserted into the intrapericardial space through the skin under the patient sternum. [0058] [0058]FIG. 5 shows the placement of cuff 12 in an intrapericardial space between a heart HT and the associated surrounding parietal pericardium PP. The diagram also shows the superior vena cava SVC, the pulmonary artery PA, the ascending aorta AA, and other veins and arteries. [0059] As depicted in FIG. 6, an inflatable intrapericardial cuff 42 may be provided with a plurality of longitudinally extending ribs 44 and a plurality of transversely extending expansion ribs 46. Each rib 46 has a memory whereby the rib may be bent for insertion and retrieval from a patient's intrapericardial space, but tends to assume a pre-established configuration (FIG. 6) upon insertion of the cuff 42 into an intrapericardial space or cavity. [0060] In another cuff insertion procedure depicted in FIGS. 7A-7C, a sharp distal tip 48 of an intrapericardial needle 50 is inserted through a patient's skin SS under the sternum ST. A dilating device 52 comprising a plurality of longitudinal ribs 54 interconnected by stretchable membranes 56 surrounds needle 50 during the insertion procedure. Upon the insertion of distal tip 48 into the intrapericardial cavity at the patient's heart, dilating device is slid in the distal direction so that a distal end portion thereof is disposed or inserted into the intrapericardial cavity. Needle 50 is then removed, as shown in FIG. 7B. [0061] Upon the removal of needle 50 from the patient, leaving dilating device 52 partially inserted into the patient's intrapericardial cavity, the dilating device may be expanded, for example, by the insertion of a series of increasing large elongate rigid dilators (not shown). Then, cuff 12 or 42 is inserted in a folded collapsed configuration into the intrapericardial cavity through the expanded dilating device 52, as shown in FIG. 7C. An inserter (not illustrated) may be used for pushing the cuff through dilating device 52. [0062] The general use and structure of dilating device 52 is described in detail in allowed U.S. patent application Ser. No. 851,097 filed Mar. 13, 1992 and U.S. patent application Ser. No. 893,991 filed Jun. 5, 1992. The disclosures of those applications are hereby incorporated by reference. [0063] As depicted in FIG. 8, an intrapericardial assist device comprises an electrode carrier in the form of an inflatable balloon 60 adapted for juxtaposition to a patient's heart in an intrapericardial space, as discussed hereinabove with reference to FIG. 5. The electrode-carrying balloon 60 has an inwardly facing surface 62 adapted for contact with the patient's heart. An array of electrical contacts or electrode wires 64 is disposed on contact surface 62 of balloon 60 for conducting electrical energy to the patient's heart upon an insertion of balloon 60 into the intrapericardial space. Current transmission elements or leads 66 are operatively connected to electrical contacts 64 for delivering electrical energy thereto from a voltage source 68. A hose 70 extends to balloon 60 for maintaining the balloon in an inflated state and thereby maintaining the balloon's contact surface 62 in adequate engagement with the patient's heart during the application of electrical energy to the heart via voltage source 68, transmission leads 66 and electrical contacts or electrodes 64. [0064] Balloon 60 is a collapsible member with a configuration of a slotted cuff in an expanded configuration. Balloon 60 has a predetermined size and shape in the expanded configuration so that it is disposable in the intrapericardial space in juxtaposition to the patient's heart. Preferably, one or more spring elements in the form of elongate ribs, e.g. 30, 32 (FIG. 2) or 44, 46 (FIG. 6), are connected to balloon 60 for automatically unfurling the balloon from a folded collapsed insertion configuration to an expanded use configuration. [0065] The means for maintaining contact surface 62 of balloon 60 in engagement with the patient's heart during a cardiac jump start as described herein includes inflation componentry 72 operatively connected to balloon 60 via hose 70. Inflation componentry 72 includes a valve device 74 which is connected to a suction source or vacuum generator 76 and to a source 78 of pressurized fluid such as water, saline solution or a gas such as air or carbon dioxide. In response to signals from a control unit 80 such as a specially programmed microprocessor, pressure source 78 and valve device 74 pressurize balloon 60 to a predetermined pressure during an electrical cardiac stimulation procedure, whereby contacts or electrodes 64 are maintained in electrically conductive contact with a patient's heart. Alternatively, during mechanical heart stimulation as described herein, control unit 80 activates valve device 74 to periodically connect balloon 60 to pressure source 78 and alternately to suction source 76, whereby balloon 60 is rapidly and forcefully inflated with a predetermined periodicity. [0066] Control unit 80 is provided with setting knobs 82 for enabling a preselection of an inflation pressure of balloon 60 and for varying the rate and maximum pressure that is applied to balloon 60 upon proper disposition thereof in the intrapericardial space about the heart. [0067] As further depicted in FIG. 8, a plurality of sensor electrodes 84 is disposed on contact surface 62 of balloon 60 for monitoring natural voltages of a cardiac cycle. Sensor electrodes 84 are connected to EKG processing circuitry 86 via leads 88. According to conventional signal processing techniques, circuitry 86 generates a signal indicative of the patient's heart activity and displays the signal via a cathode ray tube (CRT) or video screen 90. Sensor electrodes 84 and EKG processing circuitry facilitate the monitoring of heart activity during a heart resuscitation or beat regularization procedure as described below. [0068] In a surgical method for reactivating a malfunctioning heart, e.g., a stopped heart or a dangerously arrhythmic heart, balloon 60 is inserted into an intrapericardial space about the patient's heart, as discussed above with reference to FIGS. 5 and 7A-7C. Upon deployment of balloon 60 in the intrapericardial space, the balloon is inflated to place electrodes 64 in electrically conductive contact with the heart. Then, a defibrillating type voltage produced by a generator 92 of voltage source 68 is conducted via leads 66 and electrodes 64 to the patient's heart. [0069] Upon the conduction of the defibrillating type voltage to the patient's heart, heart action is monitored via electrodes 84, processing circuitry 86 and CRT 90 for a predetermined period. If it is determined at that juncture that the patient's heart has started but with an insufficiently strong action, input provided to control unit 80 via setting knobs 82 induces that unit to control valve device 74 so as to inflate balloon 60 forcefully in synchronism with a heart contraction. Synchronism may be achieved, for instance, by providing control unit 80 with input from a blood pressure and pulse sensor 94 (including, e.g., a separate pressure cuff). Alternatively, if balloon 60 is sufficiently inflated, control unit 80 may receive input from EKG processing circuitry 86. In either case, control unit or microprocessor 80 determines when a heart contraction is about to occur and opens valve device 74 to induce a flow of pressurizing fluid along hose 70 to balloon 60. The placement of a compressive pressure on the heart to thereby increase pumping action may alternatively be initiated manually by providing a triggering signal to control unit 80 via setting knobs or input 82. [0070] Balloon 60 may be at least partially deflated upon conduction of the defibrillating type voltage to the heart and prior to the monitoring of the heart action. The deflation may be only partial in the event that the heart action is monitored via sensor electrodes 84 and EKG processing circuitry 86. The deflation may be greater where the cardiac activity is determined via a conventional EKG device separate from balloon 60 and electrodes 84. [0071] To further instill a regular heart beat, a pacemaker type periodic voltage is produced by a generator 96 included, together with generator 92, in voltage source 68. The pacemaker type voltage is applied to the patient's heart via contacts or electrodes 64 upon an inflation of balloon 60 sufficient to ensure electrically conductive engagement between the heart tissues and the electrodes. Control unit 80 regulates the pressurization of balloon 60 via valve device 74 and pressure source 78. [0072] The pacemaker type voltage may be applied after a defibrillating procedure as described hereinabove and after periodic cuff inflation to strengthen the heart beat. Control unit 80 determines by the activation of a switch 98 (FIG. 9) whether a defibrillating type voltage or a pacemaker voltage is applied to the cardiac tissues. [0073] As described hereinabove with reference to FIGS. 7A-7C, the insertion of balloon 60 into the intrapericardial space may be implemented using hypodermic type needle 34. Needle 34 is inserted through a skin surface and into the intrapericardial space, balloon 60 being injected in the collapsed configuration through the needle into the intrapericardial space. As further discussed hereinabove with reference to FIGS. 7A-7C, dilating device 52 may be provided for facilitating the insertion of balloon 60 into the intrapericardial space. Needle 50 is partially inserted through the skin surface and into the intrapericardial space and a distal end portion of dilating device 52 is placed into the intrapericardial space via the needle upon the partial insertion thereof into the intrapericardial space. Dilating device 52 is subsequently expanded and balloon 60 inserted into the intrapericardial space through the expanded dilating device. [0074] As illustrated in FIG. 10, a modified intrapericardial assist device 100 comprises a balloon 102 having a predetermined size and shape in an expanded configuration so that the balloon is capable of being disposed in an intrapericardial space about a heart. Inflation componentry including a tubular member 104 and a reversible pump 106 is operatively connected to balloon 102 for inflating the balloon from an unfolded collapsed insertion configuration to the expanded configuration. Also, a feed or drip tube 108 is operatively connected to balloon 102 for delivering a lubricant 110 from a reservoir 112 to an external surface 114 of balloon 102 upon disposition of the balloon in the intrapericardial space. A manifold 116 may be provided in or along balloon 102 for delivering the lubricant 110 to a plurality of apertures or outlets 118 along surface 114. Lubricant 110 may take the form of a saline solution provided with corticosteroids for inhibiting or even preventing the formation of adhesions in the pericardial space. [0075] The lubricating componentry of FIG. 10 may be incorporated into any of the embodiments discussed above. Conversely, componentry from the above embodiments may be added to the embodiment of FIG. 10. For example, assist device 100 may include, as shown in FIG. 2, spring elements or ribs 30 and 32 which can be bent into a curled configuration (see FIG. 3) but which tend to resume their C-shaped expanded configurations when cuff 12 is placed into an intrapericardial space during a cardiopulmonary resuscitation procedure. Spring elements or ribs 30 and 32 (FIG. 2) automatically unfurl balloon 102 (FIG. 10) from a folded collapsed configuration to an unfolded collapsed configuration. [0076] Reversible pump 106 automatically and periodically inflates and alternately deflates balloon 102 upon a disposition thereof into the intrapericardial space. Pump 106 may include the elements illustrated in FIG. 1, namely, control unit 22, valves 16, suction source 18 and pressure source 20. [0077] As discussed above with reference to FIG. 8, an array of electrical contacts or electrode wires 64 (FIG. 8) may be disposed on an inner contact surface 120 of balloon 102 (FIG. 10) for conducting electrical energy to the patient's heart upon an insertion of balloon 102 into the intrapericardial space. The delivery of lubricant 110 (FIG. 10) to the intrapericardial space is useful in the embodiment of FIG. 8, where a hose 70 extends to balloon 60 for maintaining the balloon in an inflated state and thereby maintaining the balloon's contact surface 62 in adequate engagement with the patient's heart during the application of electrical energy to the heart via voltage source 68, transmission leads 66 and electrical contacts or electrodes 64. Where balloon 60 must be maintained in the pericardial space for an extended period, a saline solution provided with corticosteroids is advantageously delivered to the intrapericardial space for at least inhibiting the formation of adhesions. [0078] In assisting a malfunctioning heart with the intrapericardial assist device 100 of FIG. 10, balloon 102 is inserted into an intrapericardial space about a heart disposed in the space. Subsequently, balloon 102 is inflated in the intrapericardial space to place a compressive pressure on the heart sufficient to force blood from the heart. In addition, lubricant 110 is fed to the intrapericardial space after insertion of balloon 102 into the space. Lubricant 110 is fed to the intrapericardial space by dripping the lubricant via gravity flow along feed tube 108. The inserting of balloon 102 into the intrapericardial space is accomplished via a hypodermic type needle 34 (FIGS. 3 and 4), as discussed above with reference to FIGS. 7A-7C. The insertion may be accomplished under direct vision, where a distal end of an endoscope (not shown) is inserted into the intrapericardial space. [0079] It is to be noted that an intrapericardial assist balloon as described hereinabove can be used not only where a heart is stopped but also where the heart is functioning poorly. For example, where a patient is a candidate for a heart transplant, a cardiac assist balloon as disclosed herein may be implanted into the intrapericardial space for an extended period of time while the patient awaits for a donor heart. [0080] As illustrated in FIG. 11, an intrapericardial assist device comprises a pair of alternately inflatable and collapsible balloons 160 and 162 connected to one another so that the balloons together take on a cuff configuration 164 in an inflated or expanded state, as shown in FIG. 11. Balloons 160 and 162 are connected via respective tubes 166 and 168 to respective pressure sources 170 and 172. [0081] As illustrated in FIG. 12, pressure sources 170 and 172 each include a valve component 174 and 176. Valve components 174 and 176 are each connected to a common suction source or vacuum generator 178 and to a source 180 of pressurized fluid such as water, saline solution or a gas such as air. In response to signals from a control unit 182, valve components 174 and 176 periodically connect balloons 160 and 162 to pressure source 180 and alternately to suction source 178, whereby balloons 160 and 162 are rapidly and forcefully inflated with a predetermined periodicity. [0082] It is to be noted that control unit 182 operates valve components 174 and 176 so as to vary the onset, the duration, and/or the rate of fluid flow to balloons 160 and 162. This measure of control enables unit 182 to differentially inflate balloons 160 and 162, for example, to different maximum pressures. Such a mode of operation is desirable when a patient is afflicted with a sticky heart valve, aortic stenosis, or other condition leading to different pressures in the two ventricles. [0083] Control unit 182 may be provided with setting knobs (not illustrated) for varying the rates and maximum pressures that are applied to balloons 160 and 162 upon proper disposition thereof in the intrapericardial space about the heart. [0084] Spring elements or ribs 184 and 188 are disposed in walls of balloons 160 and 162 for unfurling balloons 160 and 162 from a folded or furled configuration to an expanded configuration upon a placement of cuff 164 into an intrapericardial space. [0085] The deployment of cuff 164 and accordingly balloons 160 and 162 is implemented according to the procedure described hereinabove with reference to FIGS. 3 and 4. The embodiment of FIGS. 11 and 12 may incorporate any of the various features described hereinabove with respect to FIGS. 1-10. [0086] [0086]FIG. 13 illustrates a medical device 208 for use in performing surgery as discussed below with reference to FIGS. 14A through 14D to improve cardiac function in part by reducing the effective volume of the ventricles and in part by repeatedly exerting a compressive force on the reduced-volume ventricles to force blood out of the ventricles during a systolic phase of a cardiac cycle. The compressive device of FIG. 13 includes a cardiac clamp 210 in the form of a plurality of elongate prongs or tines 212 connected in a substantially circular or oval configuration to a base 214. Prongs 212 have an inherent spring bias which tends to spread the prongs into a conical configuration as depicted in FIG. 13 and 14B. Prongs 212 are each provided with at least one tooth 216 which faces inwardly relative to the spread-open conical configuration. [0087] Device 208 further includes an inner tubular member 218 in which clamp 210 is disposed in a collapsed configuration at the onset of a surgical procedure. More specifically, clamp 210 is disposed inside a distal end portion of tubular member 218 prior to an ejection of the clamp by a distally directed motion of a rod 220. Prior to use, rod 220 may be disposed outside of tubular member 218. It is preferable, however, that rod be disposed partially inside tubular member 218 during initial deployment thereof during a cardiac operation as discussed below. [0088] An elastic band 222 is disposed about tubular member 218 at the distal end thereof. A second tubular member 224 surrounds tubular member 218 for pushing band 222 off of the distal end of tubular member 218 as discussed below. [0089] As illustrated in FIG. 14A, a distal end portion of tubular member 218 is inserted through parietal pericardium PP into an intrapericardial space IP surrounding a patient's heart HT. Tubular member 218 may be deployed in an open heart surgical operation or alternatively in a minimally invasive operation. In the latter case, tubular member is inserted through a thoracoscopic cannula or trocar sleeve 226. [0090] Tubular member 218 is inserted from below the heart HT so that the distal end is pointed upwardly substantially parallel to the septum (not shown). After a proper positioning of tubular member 218, rod 220 is pushed in the distal direction, towards an apical portion AP of the heart HT to eject clamp 210, as shown in FIG. 14A. Upon the ejection of clamp 210, prongs 212 automatically spread open under their inherent spring bias to form a conical configuration. The entire instrument assembly is then moved towards heart HT so that the opened clamp 210 surrounds apical portion AP, as illustrated in FIG. 14B. Subsequently, inner tubular member 218 is pushed forward, over clamp 210, as depicted in FIG. 14C. Prongs 212 are pressed inwardly in a camming type action so that teeth 216 bite into the myocardium of heart HT and anchor clamp 210 thereto. Continued forward or distal motion of inner tubular member 218 relative to clamp 210 serves to compress apical portion AP of heart HT, as shown in FIG. 14C. To some extent, prongs 212 pivot about the connecting points to base 214 in response to the camming action of tubular member 218. [0091] After the positioning and partial closure of clamp 210 about the apical portion AP of heart HT, outer tubular member 224 is shifted in the distal direction toward heart, while clamp 210 and inner tubular member 218 are maintained in position about apical heart portion AP. This relative motion serves to slide or push elastic band 222 off of tubular member 218 and onto the closed clamp 210. As illustrated in FIG. 14D, band 222 is left in place on clamp 210 to hold pongs 212 in a partially closed configuration compressing apical portion AP of heart HT and reducing the volume of both ventricles of the heart. The reduced volume makes the pumping action of the heart more efficient and improves blood circulation in individuals suffering from congestive heart failure or left ventricular hypertrophy. [0092] As further illustrated in FIG. 14D, a cuff-shaped balloon 228 is positioned in the intrapericardial space IP generally above the closed clamp 210. A tube 230 extends from balloon 228 to a pressure source (not illustrated). The structure, function and deployment of balloon 228 are as discussed above, for instance, with reference to FIGS. 1-10. In most cases, balloon 228 is repeatedly and forcibly inflated to squeeze blood from the ventricles (not shown)of heart HT to assist in pulsatile blood circulation. [0093] As illustrated in FIG. 15, a cardiac assist device 232 comprises a first balloon 234 and a second balloon 236. Balloons 234 and 236 are optionally connected to one another and positioned in an intrapericardial space (not shown) in a single deployment or insertion operation. Balloon 234 assumes a generally cup shape in an inflated configuration, while balloon 236 assumes a generally cylindrical configuration when inflated. Balloons 234 and 236 are formed with slots or gaps 238 and 240 for purposes of facilitating disposition about heart HT. Tubes 242 and 244 extend from balloons 234 and 236 to respective pressure sources 246 and 248. Pressure source 248 periodically or repeatedly inflates and alternately deflates balloon 236 during a cardiac assist operation, while pressure source 246 functions to inflate balloon 234 and to maintain that balloon in its expanded configuration during the cyclic inflation and deflation of balloon 236. [0094] [0094]FIG. 16A through 16F illustrate an alternative procedure for reducing ventricular volume in a cardiac assist operation. As shown in FIG. 16A, a catheter 250 is inserted through a patient's vascular system into one of the ventricles LV and RV of the patient's heart HT, for example, the right ventricle RV. Catheter 250 has a leading end portion 252 which is steerable to enable a directing of a mouth opening 254 toward a sidewall SW1 of the patient's myocardium MYO. As shown in FIG. 16B, a wire 256 is ejected from catheter 250 through mouth opening 254 into and partially through myocardial sidewall SW1 upon a positioning of the mouth opening adjacent to the sidewall. Wire 256 is provided at a leading end with a plurality of barbs or arrow heads 258 preventing a withdrawal of the wire along its insertion path through myocardial sidewall SW1. Upon an embedding of barbs 258 in myocardial sidewall SW1, catheter 250 is manipulated to steer leading end portion 252 towards cardiac septum SPM, as illustrated in FIG. 16C. Then a second wire 260 is ejected from catheter 250 through mouth opening 254 and septum SPM into and partially through an opposing myocardial sidewall SW2, as depicted in FIG. 16D. Wire 260 is provided at a leading end with a plurality of barbs or arrow heads 262 preventing a detachment of the wire from myocardial sidewall SW2. Upon an embedding of barbs 262 in myocardial sidewall SW2, catheter 250 and wires 256 and 260 are manipulated to twist wires 256 and 260 about one another, as indicated by an arrow 264 and wire coils 266 in FIG. 16E. This twisting action exerts tension on wires 256 and 260 and is performed until sidewalls SW1 and SW2 are drawn sufficiently close to one another, as shown in FIG. 16F, to effectively reduce the volumes of ventricles RV and LV. Wires 256 and 260 are thereafter severed by any practicable technique including but not limited to shearing, laser cutting, etc. A cuff-shaped balloon 268 may then be deployed and operated as discussed above with reference to FIGS. 1-10, 14D and 15. [0095] A cardiac assist device as described above may additionally be provided with an ultrasonic sensor for use in monitoring blood flow in and/or from the ventricles upon deployment of the cardiac assist device. The ultrasonic (Doppler) sensor may be attached to the cardiac assist device, for instance, to the pulsating balloon. [0096] As illustrated in FIG. 17A, a method for reducing ventricular volume to improve cardiac functioning includes a step of inserting a distal or leading end portion of a catheter 320 through the vascular system of a patient, and particularly through the vena cava, into the right ventricle 322 of the patient's heart 324. The deployment of catheter 320 is carried out according to procedures that are well known in the art. For example, the catheter 320 may be introduced over a guide wire (not shown) which has been previously threaded through the venous system to the right ventricle 322. [0097] After the distal end portion of catheter 320 has been inserted through the right auricle (not shown) into the right ventricle 322, the catheter is manipulated to place a leading end or tip 326 of catheter 320 into engagement with a lower part of a septum 328 of the patient's heart 324, as shown in FIG. 17B. A compressive cardiac implant or insert in the form of a tensile member 330 such as a wire or a stiff suture is then forcibly ejected from the catheter 320 through septum 328, a lower part of the patient's left ventricle 332, and a generally left wall or myocardium region 334 of the patient's heart 324. [0098] As further illustrated in FIG. 17B, tensile member 330 is formed at a leading end with an anchor 336 in the form of a barb or flange. Anchor 336 has a structure which permits movement of the anchor in one direction through cardiac tissues and prohibits movement of the anchor in the opposite direction through the tissue. For instance, anchor 336 may be hinged to the leading end of tensile member 330 and formed with a stop for arresting rotational motion beyond a predetermined orientation relative to tensile member 320. Prior to the ejection of tensile member 330 from catheter 320, anchor 336 is disposed in a collapsed configuration inside catheter 320. Anchor 336 essentially maintains this collapsed configuration during the ejection process. [0099] After anchor 336 has passed through heart wall 334, a retraction force is applied to tensile member 330 tending to draw the tensile member back in the catheter 320. As shown in FIG. 17C, this action results in the planting of anchor 336 along the outer side of wall 334 and a drawing together of the lower parts of septum 328 and wall region 334. Septum 328 and heart wall 334 are thus brought into at least approximate contact with one another to effectively close off a lower or apical portion of heart 324, as illustrated in FIG. 17C. [0100] After the limited retraction of tensile member 330 and the consequent closure of the lower or apical portion of heart 324, tensile member 330 is provided with a second anchor 338, as shown in FIG. 17D, and severed on a side of septum 328 inside right ventricle 322. Anchor 338 may be similar in structure to anchor 336 (but oppositely biased) and permanently attached thereto. In that case, tensile member 330 with anchors 336 and 338 is preselected, prior to insertion in catheter 320, to match the particular heart 324 and deployment location. More specifically, tensile member 330 and anchors 336 and 338 together define a preformed compressive cardiac implant having an interanchor spacing equal to the combined thickness of septum 328 and heart wall 334 at the intended point of deployment of the cardiac implant. The thicknesses of septum 328 and heart wall 334 may be premeasured by a CAT scan or magnetic resonance imaging or through radiographic investigation. Anchor 338 is held in a collapsed configuration by a sleeve (not shown) inside catheter 320, thus enabling a relative motion of anchor 338 in a distal direction (relative to the operator or surgeon) during an implantation operation. [0101] In an alternative structure and method of deployment, anchor 338 is permanently fixed to tensile member 330 only after the ejection of tensile member 330 through septum 328, left ventricle 332, and heart wall 334. Prior to the ejection operation, anchor 338 is housed inside catheter 330 and surrounds tensile member 330. After ejection of tensile member 330, anchor 338 is pushed by an ancillary tubular member (not shown) into contact with the right-ventricle side of septum 328. Anchor 338 is then secured to tensile member 330 by any suitable means. For instance, where tensile member 330 and anchor 338 are made of thermosetting resin or polymeric material, a piezoelectric crystal may be inserted into right ventricle 322 through catheter 320 to ultrasonically weld anchor 338 to tensile member 330. Alternatively, tensile member 330 may be formed with a series of spaced beads and anchor 38 made of an elastic biocompatible material, so that anchor 338 may be pushed over one or more of the beads and locked to tensile member in a snap-lock fit. [0102] The severing of tensile member 330 on a side of anchor 338 opposite septum 328 is effectuated by any suitable means. A cutting device (not shown) may be inserted into right ventricle 322 and subsequently removed therefrom via catheter 320. Possible kinds of cutting devices for this application have jaws (not shown) or an ultrasonically actuated blade (not shown). Alternatively, catheter 320 might be rotated about its longitudinal axis to effectuate a twisting separation of tensile member 330. [0103] As illustrated in FIG. 18A, another method for reducing ventricular volume to improve cardiac functioning of the patient's heart 324 includes a step of inserting a distal or leading end portion of a catheter 340 through the vascular system of the patient, and particularly through the aorta (not shown), into the left ventricle 332 of the heart 324. Again, the particulars of deploying deployment catheter 340 are well known in the art. [0104] After the distal end portion of catheter 340 has been inserted through the left auricle (not shown) into the left ventricle 332, the catheter is manipulated to place a leading end or tip 342 of catheter 340 into engagement with a lower part of a septum 328 of the patient's heart 324, as shown in FIG. 18A. A compressive cardiac implant or insert segment in the form of a tensile member or wire 344 is then forcibly ejected from the catheter 340 through septum 328, as depicted in FIG. 18B. Tensile member 344 is formed at a leading end with an anchor 346 in the form of a barb or flange. As discussed above with reference to anchor 336, anchor 346 has a structure which permits movement of the anchor in one direction through cardiac tissue and prohibits movement of the anchor in the opposite direction through the tissue. Again, anchor 346 may be hinged to the leading end of tensile member 344 and formed with a stop for arresting rotational motion beyond a predetermined orientation relative to tensile member 344. Prior to the ejection of tensile member 344 from catheter 340, anchor 346 is disposed in a collapsed configuration inside catheter 40. Anchor 346 essentially maintains this collapsed configuration during the ejection process. [0105] After the piercing of septum 328 by tensile member 344, catheter 340 is withdrawn slightly, as shown in FIG. 18B. Then, catheter 340 is manipulated to place end or tip 342 into engagement with a lower part of heart wall 334, as shown in FIG. 18C. A second compressive cardiac implant or insert segment in the form of a tensile member or wire 348 is then forcibly ejected from the catheter 40 through heart wall 334, as depicted in FIG. 18C. Tensile member 348 is also formed at a leading end with an anchor 350 in the form of a barb or flange. [0106] After the piercing of heart wall 334 by tensile member 348, catheter 340 is again pulled back slightly to a position depicted in FIG. 18D. At that juncture, catheter 340 is turned about its longitudinal axis, as indicated by an arrow 352, to twist tensile members or wire segments 344 and 348. Catheter 340 may be provided at its leading end with a cross-bar (not shown) to facilitate the twisting of tensile members or wire segments 344 and 348 about one another, tensile members or wire segments 344 and 348 extending on opposite sides of the cross-bar. The twisting of tensile members or wire segments 344 and 348 draws septum 328 and heart wall 334 together, as shown in FIG. 18E. Eventually, the twisting results in severing of tensile members or wire segments 344 and 48 so that they are joined to one another by a twist knot 354. [0107] As shown in FIG. 19, a compressive cardiac implant of insert 356 in the form of a tack is ejected from a free end 358 of a tubular applicator 60 through heart wall 334, left ventricle 332, and septum 328. Applicator 360 is inserted into an intrapericardial space 362 through a thoracoscopic cannula or trocar sleeve 364. Tack 356 is formed at a leading end with an anchor 366 in the form of a barb or flange. Anchor 366 has a structure which permits movement of the anchor in one direction through cardiac tissues and prohibits movement of the anchor in the opposite direction through the tissue. [0108] After the ejection of tack 356 through ventricle 332, a tensile force is placed on tack 356 to draw the tack in a reverse direction and thereby compress the lower portion or apex of ventricle 332 between anchor 366 and the leading end of tubular applicator 360. After the limited retraction of tack 356 and the consequent closure of the lower or apical portion of heart 324, tack 356 is provided with a second anchor (not shown) and severed on a side of heart wall 334 inside the intrapericardial space 362. Where this second, closure, anchor is in the form of a resilient collar and where tack 356 is provided with a series of beads (not shown), the collar may be forced over the beads in seriatim to provide a proper clamping force on the cardiac tissues at the lower end or apex of ventricle 332, thereby bringing septum 328 and heart wall 334 into close proximity (if not actual contact) with one another and thus substantially closing the apical portion of ventricle 332. [0109] [0109]FIG. 20 illustrates a modification of the procedure described hereinabove with reference to FIGS. 16A through 16F. Wires 256 and 260 are ejected from mouth opening 254 of catheter 250 so that free ends of wires 256 and 260, including barbs 258 and 262, are completely embedded in outer sidewalls SW1 and SW2 of the myocardium MYO. The free ends of wires 256 and 260, including barbs 258 and 262, are completely surrounded by the myocardium MYO so that the implanted compressive or tensile device is contained entirely within the heart and does not protrude into the intrapericardial space (not shown). [0110] [0110]FIG. 21 illustrates an analogous modification of the procedure discussed above with reference to FIGS. 18A through 18F. Free ends of wires or tensile members 370 and 372, provided with plural barbs or teeth 374 and 376, are completely embedded in a septum 378 and an outer wall 380 of a patient's heart. The free ends of wires 370 and 372, including barbs 374 and 376, are completely surrounded by the septum 378 and the outer heart wall 380 so that the implanted compressive or tensile device is contained entirely within the heart and does not protrude into the intrapericardial space (not shown). [0111] A like modification (not specifically illustrated) may be made in the technique depicted in FIGS. 17A though 17D. In that case, only the barbed end 336 of wire 330 is embedded completely within heart tissue. The trailing anchor 338 remains in communication with the right ventricle 322 of the patient. In any event, the implanted compressive or tensile device is contained entirely within the patient's heart and does not protrude into the intrapericardial space. [0112] Although the invention has been described in terms of particular embodiments and applications, one of ordinary skill in the art, in light of this teaching, can generate additional embodiments and modifications without departing from the spirit of or exceeding the scope of the claimed invention. For example, there are alternative methods for inserting a balloon type cardiac assist device into the intrapericardial space. Such alternative methods include placing the balloon(s) through a laparoscopic cannula inserted either through the rib cage and alongside the sternum, or below the rib cage and above the diaphragm. The installation of an intrapericardial assist device may be accomplished nearly under direct vision, through a small incision beneath the ribs, without splitting any ribs. [0113] Furthermore, other mechanisms for closing a compressive device about a lower end of a patient's heart will be apparent to those skilled in the art. Such mechanisms will generally contemplate the conversion of an axially directed force to a compressive force. In one alternative design, instead of pushing tubular member 218 about the expanded clamp 210, a screw mechanism may be used to close, and possibly open, prongs 212. In another alternative design, a cup-shaped clamp has a plurality of relative movable leaves, as in a mechanical iris. [0114] It is to be noted, in addition, that device 208 may be used to place clamp 210 about a part of the heart HT other than apical portion AP. Thus, device 208 may approach the heart HT from a different direction, for example, where it is desired to reduce the effective volume of the left ventricle only. [0115] Prongs 212 may be spring biased to close clamp 210. In that case, the inserting instrument is adapted to spread prongs 212 into a opened configuration in opposition to the action of inherent spring forces. When the opening force is removed, the clamp squeezes the hear muscle and compresses a portion of the heart. [0116] A catch may be provided on prongs 212 for holding band 222 on clamp 210 after the disposition of band about the clamp. [0117] Accordingly, it is to be understood that the drawings and descriptions herein are proffered by way of example to facilitate comprehension of the invention and should not be construed to limit the scope thereof. Referenced byCiting PatentFiling datePublication dateApplicantTitleUS6537198Mar 21, 2000Mar 25, 2003Myocor, Inc.Splint assembly for improving cardiac function in hearts, and method for implanting the splint assemblyUS6616684Oct 6, 2000Sep 9, 2003Myocor, Inc.Endovascular splinting devices and methodsUS6723038Oct 6, 2000Apr 20, 2004Myocor, Inc.Methods and devices for improving mitral valve functionUS6764510Jan 9, 2002Jul 20, 2004Myocor, Inc.Devices and methods for heart valve treatmentUS6776754 *Oct 4, 2000Aug 17, 2004Wilk Patent Development CorporationMethod for closing off lower portion of heart ventricleUS7276032Sep 29, 2004Oct 2, 2007Ethicon Endo-Surgery, Inc.Biopsy apparatus and methodUS7320665Jul 14, 2006Jan 22, 2008Venkataramana VijayCardiac Ventricular Geometry Restoration Device and Treatment for Heart FailureUS7402813Dec 13, 2006Jul 22, 2008Spectrum Dynamics LlcLens system for nuclear medicine gamma ray cameraUS7666224Jul 7, 2005Feb 23, 2010Edwards Lifesciences LlcDevices and methods for heart valve treatmentUS7678145Jul 1, 2005Mar 16, 2010Edwards Lifesciences LlcDevices and methods for heart valve treatmentUS7695425Feb 17, 2004Apr 13, 2010Edwards Lifesciences LlcHeart wall tension reduction apparatus and methodUS7722523Jul 9, 2002May 25, 2010Edwards Lifesciences LlcTransventricular implant tools and devicesUS7766812Apr 14, 2006Aug 3, 2010Edwards Lifesciences LlcMethods and devices for improving mitral valve functionUS7818063Jan 25, 2007Oct 19, 2010Boston Scientific Scimed, Inc.Method of intravascularly delivering stimulation leads into brain to stimulate the SPGUS7883538 *Feb 8, 2011Guided Delivery Systems Inc.Methods and devices for terminationUS7883539Apr 23, 2002Feb 8, 2011Edwards Lifesciences LlcHeart wall tension reduction apparatus and methodUS7937160May 3, 2011Boston Scientific Neuromodulation CorporationMethods for delivering cortical electrode leads into patient's headUS8007428Aug 30, 2011Venkataramana VijayCardiac ventricular geometry restoration device and treatment for heart failureUS8019441 *Jul 24, 2006Sep 13, 2011Boston Scientific Neuromodulation CorporationCollapsible/expandable tubular electrode leadsUS8060207Nov 15, 2011Boston Scientific Scimed, Inc.Method of intravascularly delivering stimulation leads into direct contact with tissueUS8066766Aug 20, 2007Nov 29, 2011Guided Delivery Systems Inc.Methods and devices for terminationUS8070805Jan 25, 2010Dec 6, 2011Edwards Lifesciences LlcDevices and methods for heart valve treatmentUS8103350Jun 11, 2007Jan 24, 2012Boston Scientific Neuromodulation CorporationMethod of stimulation fastigium nucleus to treat neurological disordersUS8185208May 22, 2012Boston Scientific Neuromodulation CorporationModular stimulation lead networkUS8226711Jul 24, 2012Edwards Lifesciences, LlcValve to myocardium tension members device and methodUS8267852Jul 8, 2010Sep 18, 2012Edwards Lifesciences, LlcHeart wall tension reduction apparatus and methodUS8287557Oct 16, 2012Guided Delivery Systems, Inc.Methods and devices for terminationUS8303481 *Nov 6, 2012Cvdevices, LlcDevices and methods for assisting heart functionUS8343173Jan 1, 2013Guided Delivery Systems Inc.Delivery devices and methods for heart valve repairUS8382651 *Apr 18, 2008Feb 26, 2013Cvdevices, LlcDevices, systems, and methods to facilitate heart functionUS8394008Jul 29, 2010Mar 12, 2013Bioventrix, Inc.Steerable lesion excluding heart implants for congestive heart failureUS8425402Apr 23, 2013Bioventrix, Inc.Cardiac anchor structures, methods, and systems for treatment of congestive heart failure and other conditionsUS8449442May 28, 2013Bioventrix, Inc.Method and device for percutaneous left ventricular reconstructionUS8460173Jun 11, 2013Edwards Lifesciences, LlcHeart wall tension reduction apparatus and methodUS8491455Oct 3, 2008Jul 23, 2013Bioventrix, Inc.Treating dysfunctional cardiac tissueUS8506474 *Aug 21, 2006Aug 13, 2013Bioventrix, Inc.Method and device for treating dysfunctional cardiac tissueUS8506624Dec 2, 2011Aug 13, 2013Edwards Lifesciences, LlcDevices and methods for heart valve treatmentUS8636639Jan 24, 2012Jan 28, 2014Bioventrix, Inc.Signal transmitting and lesion excluding heart implants for pacing, defibrillating, and/or sensing of heart beatUS8731674Jan 10, 2012May 20, 2014Boston Scientific Neuromodulation CorporationMethod of stimulating fastigium nucleus to treat neurological disordersUS8795298Oct 9, 2009Aug 5, 2014Guided Delivery Systems Inc.Tether tensioning devices and related methodsUS8968175Jul 23, 2013Mar 3, 2015Bioventrix, Inc.Treating dysfunctional cardiac tissueUS8979750Sep 30, 2012Mar 17, 2015Bioventrix, Inc.Trans-catheter ventricular reconstruction structures, methods, and systems for treatment of congestive heart failure and other conditionsUS8986189Jul 1, 2010Mar 24, 2015Bioventrix, Inc.Method and apparatus for closing off a portion of a heart ventricleUS9023065Jun 9, 2011May 5, 2015Aptus Endosystems, Inc.Devices, systems, and methods for supporting tissue and/or structures within a hollow body organUS9039594Jan 28, 2014May 26, 2015Bioventrix, Inc.Signal transmitting and lesion excluding heart implants for pacing, defibrillating, and/or sensing of heart beatUS9044231Mar 11, 2013Jun 2, 2015Bioventrix, Inc.Steerable lesion excluding heart implants for congestive heart failureUS9072513Aug 6, 2008Jul 7, 2015Guided Delivery Systems Inc.Methods and devices for terminationUS9095363Sep 30, 2012Aug 4, 2015Bioventrix, Inc.Remote pericardial hemostasis for ventricular access and reconstruction or other organ therapiesUS9101338May 3, 2007Aug 11, 2015Mayo Foundation For Medical Education And ResearchSoft body tissue remodeling methods and apparatusUS9119720May 20, 2013Sep 1, 2015Bioventrix, Inc.Method and device for percutaneous left ventricular reconstructionUS9173711Sep 30, 2012Nov 3, 2015Bioventrix, Inc.Cardiac implant migration inhibiting systemsUS9173712Sep 30, 2012Nov 3, 2015Bioventrix, Inc.Over-the-wire cardiac implant delivery system for treatment of CHF and other conditionsUS9198757Jul 7, 2009Dec 1, 2015Edwards Lifesciences, LlcMethods and devices for improving mitral valve functionUS9211115May 21, 2007Dec 15, 2015Bioventrix, Inc.Location, time, and/or pressure determining devices, systems, and methods for deployment of lesion-excluding heart implants for treatment of cardiac heart failure and other disease statesUS9259318 *Apr 19, 2007Feb 16, 2016Beth Israel Deaconess Medical CenterPericardial reinforcement deviceUS9259319Aug 13, 2013Feb 16, 2016Bioventrix, Inc.Method and device for treating dysfunctional cardiac tissueUS9295768Feb 26, 2013Mar 29, 2016Cvdevices, LlcDevices and methods for assisting cardiac functionUS9320503Oct 20, 2005Apr 26, 2016Medtronic Vascular, Inc.Devices, system, and methods for guiding an operative tool into an interior body regionUS9320513Mar 13, 2015Apr 26, 2016Bioventrix, Inc.Trans-catheter ventricular reconstruction structures, methods, and systems for treatment of congestive heart failure and other conditionsUS9320589Jun 16, 2011Apr 26, 2016Medtronic Vascular, Inc.Endovascular aneurysm repair systemUS20040102674 *Nov 26, 2002May 27, 2004Zadini Filiberto P.Minimally invasive percutaneous ventricular assist deviceUS20050203600 *Mar 12, 2004Sep 15, 2005Scimed Life Systems, Inc.Collapsible/expandable tubular electrode leadsUS20060074344 *Sep 29, 2004Apr 6, 2006Hibner John AFluid control for biopsy deviceUS20060074346 *Sep 29, 2004Apr 6, 2006Hibner John ABiopsy apparatus and methodUS20060199995 *Mar 2, 2005Sep 7, 2006Venkataramana VijayPercutaneous cardiac ventricular geometry restoration device and treatment for heart failureUS20060259110 *Jul 24, 2006Nov 16, 2006Boston Scientific Scimed, Inc.Collapsible/Expandable Tubular Electrode LeadsUS20070073274 *Aug 21, 2006Mar 29, 2007Sing-Fatt ChinMethod and device for treating dysfunctional cardiac tissueUS20070145281 *Dec 13, 2006Jun 28, 2007Shlomo Ben-HaimLens System For Nuclear Medicine Gamma Ray CameraUS20070282375 *May 3, 2007Dec 6, 2007St. Jude Medical, Inc.Soft body tissue remodeling methods and apparatusUS20080021266 *Apr 19, 2007Jan 24, 2008Laham Roger JPericardial reinforcement deviceUS20080064917 *Oct 15, 2004Mar 13, 2008Eli BarAmplification-Based Cardiac Assist DeviceUS20080097148 *Dec 20, 2007Apr 24, 2008Chf Technologies, Inc.Method and device for percutaneous left ventricular reconstructionUS20080177130 *Jan 22, 2008Jul 24, 2008Venkataramana VijayCardiac Ventricular Geometry Restoration Device and Treatment for Heart FailureUS20080275294 *Jul 12, 2007Nov 6, 2008Michael GertnerPericardial insertsUS20080275295 *Jul 12, 2007Nov 6, 2008Michael GertnerMethods of using pericardial insertsUS20080294251 *May 21, 2007Nov 27, 2008Bioventrix (A Chf Technologies' Company)Location, time, and/or pressure determining devices, systems, and methods for deployment of lesion-excluding heart implants for treatment of cardiac heart failure and other disease statesUS20090093670 *Oct 3, 2008Apr 9, 2009Bioventrix (A Chf Technologies, Inc.)Treating Dysfunctional Cardiac TissueUS20100016655 *Jan 21, 2010Bio Ventrix (a CHF Technologies, Inc.Cardiac Anchor Structures, Methods, and Systems for Treatment of Congestive Heart Failure and Other ConditionsUS20100185044 *Mar 12, 2010Jul 22, 2010Cvdevices, Llc (A California Limited Liability Company)Devices and methods for assisting heart functionUS20100268020 *Jul 1, 2010Oct 21, 2010Bioventrix (A Chf Technologies, Inc.)Method and Apparatus For Closing Off a Portion of a Heart VentricleUS20110160750 *Jul 29, 2010Jun 30, 2011BioVentrix (a CHF Technologies Company)Steerable Lesion Excluding Heart Implants For Congestive Heart FailureUS20110245645 *Oct 8, 2009Oct 6, 2011Hannes Goetz KenngottArrangement for implanting and method for implantingUS20120059446 *Sep 12, 2011Mar 8, 2012Boston Scientific Scimed, Inc.Collapsible/expandable tubular electrode leadsUS20120130151 *Apr 18, 2008May 24, 2012Kassab Ghassan SDevices, systems, and methods to facilitate heart functionEP1734872A1 *Feb 22, 2005Dec 27, 2006Aptus endosystems, Inc.Devices, systems, and methods for supporting tissue and/or structures within a hollow body organEP1734872A4 *Feb 22, 2005Apr 30, 2014Aptus Endosystems IncDevices, systems, and methods for supporting tissue and/or structures within a hollow body organEP1748808A1 *May 10, 2005Feb 7, 2007PPA Technologies AGDevice for epicardial support and/or resumption of cardiac activityEP2142233A2 *Apr 18, 2008Jan 13, 2010Cvdevices, LlcDevices, systems, and methods to facilitate heart functionWO2004082538A3 *Mar 17, 2004Apr 14, 2004Todd A BergBody tissue remodeling apparatusWO2005102181A1Feb 22, 2005Nov 3, 2005Aptus Endosystems, Inc.Devices, systems, and methods for supporting tissue and/or structures within a hollow body organWO2005110512A1May 10, 2005Nov 24, 2005Ppa Technologies AgDevice for epicardial support and/or resumption of cardiac activityWO2009127384A2 *Apr 14, 2009Oct 22, 2009Ppa Technologies GmbhDevice and system for supporting and/or take-over of the pumping function of the heartWO2009127384A3 *Apr 14, 2009Mar 4, 2010Ppa Technologies GmbhDevice and system for supporting and/or take-over of the pumping function of the heart* Cited by examinerClassifications U.S. Classification600/16, 128/898International ClassificationA61B17/00, A61B17/12, A61M1/10, A61B17/30, A61B17/22, A61B19/00Cooperative ClassificationA61B2090/0815, A61B17/221, A61B2017/303, A61M1/106, A61F2/2481, A61B2017/00243, A61B17/00234, A61M1/1065, A61B2017/00557, A61M1/1062, A61B2017/2215, A61B2017/00154, A61B2017/048, A61M1/1068, A61B17/12013, A61F2/2487, A61B2017/00703European ClassificationA61F2/24W2, A61M1/10E50B, A61B17/00E, A61M1/10E4HLegal EventsDateCodeEventDescriptionNov 12, 2002ASAssignmentOwner name: WILK PATENT DEVELOPMENT CORPORATION, NEW YORKFree format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:WILK, PETER J.;REEL/FRAME:013238/0797Effective date: 20021112Dec 20, 2006REMIMaintenance fee reminder mailedMay 30, 2007FPAYFee paymentYear of fee payment: 4May 30, 2007SULPSurcharge for late paymentFeb 3, 2009DIAdverse decision in interferenceNov 23, 2010FPAYFee paymentYear of fee payment: 8Aug 27, 2012ASAssignmentOwner name: BIOVENTRIX, INC., CALIFORNIAFree format text: MERGER;ASSIGNOR:CHF TECHNOLOGIES, INC.;REEL/FRAME:028857/0413Effective date: 20120615Jan 9, 2015REMIMaintenance fee reminder mailedJun 3, 2015LAPSLapse for failure to pay maintenance feesJul 21, 2015FPExpired due to failure to pay maintenance feeEffective date: 20150603RotateOriginal ImageGoogle Home - Sitemap - USPTO Bulk Downloads - Privacy Policy - Terms of Service - About Google Patents - Send FeedbackData provided by IFI CLAIMS Patent Services